Alerts will be sent to your verified email
Verify Email
BAFNAPH
|
Bafna Pharma
|
Ambalal Sarabhai Ent
|
Chemkart India
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-52.11 % | 19.11 % | 57.15 % |
|
5yr Avg Net Profit Margin
|
-36.55 % | 10.89 % | 8.77 % |
|
Price to Book
|
4.85 | 1.71 | 4.56 |
|
P/E
|
29.95 | 18.65 | 10.01 |
|
5yr Avg Cash Conversion Cycle
|
0.18 Days | -37.53 Days | 74.43 Days |
|
5yr Average Interest Coverage Ratio
|
-5.68 | 9.88 | 26.3 |
|
5yr Avg ROCE
|
-11.61 % | 24.01 % | 78.81 % |
|
5yr Avg Operating Profit Margin
|
-21.98 % | 5.29 % | 12.11 % |
|
5 yr average Debt to Equity
|
1.41 | 0.32 | 0.59 |
|
5yr CAGR Net Profit
|
12.0 % | -30.01 % | 34.67 % |
|
5yr Average Return on Assets
|
-16.11 % | 8.69 % | 24.52 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.0 % | 31.35 % | 73.31 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-15.12 % | 0.59 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bafna Pharma
|
Ambalal Sarabhai Ent
|
Chemkart India
|
|---|